Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin in Chronic Bacterial Prostatitis
NCT00277511Phase 3Completed
- Sponsor
- Sanofi
- Start
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levofloxacin in chronic bacterial prostatitis (CBP), sponsored by Sanofi. Primary endpoint: Microbiological Eradication Rate. Started Mar 2003; status: completed.
02
Drugs
levofloxacin
03
Conditions
chronic bacterial prostatitis (CBP)
Beyond the preview
Go deeper on NCT00277511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00277511.